Most Favored Patient Act of 2026
Rep. Meuser Introduces Most Favored Patient Act to Tie U.S. Drug Prices to Lower International Rates
Legislative Progress
Key Points
- This bill would limit the amount Medicare and Medicaid pay for many prescription drugs. The price would be capped at the second-lowest price paid for that same drug in a group of eight other countries, including Canada, France, and the United Kingdom.
- The policy would help millions of seniors and low-income Americans by lowering the cost of medications they get at the pharmacy or have administered by a doctor, such as cancer treatments or specialized injections.
- Drug companies could avoid these strict price caps if they sign a special agreement with the government. To do this, they must agree to the lower prices and also commit to creating more manufacturing jobs within the United States.
- This plan is designed to address the fact that Americans often pay significantly more for the exact same medications than people in other wealthy nations.
- If the bill becomes law, the government would start testing this new pricing system on January 1, 2029, and the program would last for five years.
Impact Analysis
Personal Impact
Life & Work
Independent pharmacies and small healthcare businesses could face mixed effects. While lower drug prices may benefit patients, the specific pricing structure could squeeze pharmacy margins on affected drugs. The bill requires manufacturers to provide the lower prices to pharmacies and dispensers, but how reimbursement adjustments play out for small pharmacy owners remains uncertain.
Programs
Disabilities
Milestones
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sent to a congressional committee for expert review. The committee decides whether this bill moves forward.
Introduced in House
The bill was officially filed and given a number. It now enters the legislative queue.
Votes
No votes have been recorded for this legislation yet.
News
No related news coverage found for this legislation yet.
Source Information
Document Type
Congressional Bill
Official Title
Most Favored Patient Act of 2026
Data Sources
Sponsor
Analysis generated by AI. Always verify with official sources.